{"id":534772,"date":"2021-09-07T08:04:54","date_gmt":"2021-09-07T12:04:54","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/"},"modified":"2021-09-07T08:04:54","modified_gmt":"2021-09-07T12:04:54","slug":"optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/","title":{"rendered":"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021"},"content":{"rendered":"<h2>\nOptimizeRx Recognized in the COVID-19 Pandemic-Related Campaign Category<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p align=\"left\">ROCHESTER, Mich., Sept.  07, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=HdnVRvPl1dlzjh0SqblQ4E0KqBZHZi7EFBd7cWC32gn57llt_Sp9j28ekfPwfH_rCbSnIc11KmHlrFlpnxowqwhdXGbOkf6wEmHdjWeovSc=\" rel=\"nofollow noopener\" target=\"_blank\">OptimizeRx Corp.<\/a> (the \u201cCompany\u201d) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that it has been selected as a finalist in the 2021 Fierce Pharma Marketing Awards which honor leadership, vision, innovation and strategic accomplishments within the pharma marketing and advertising arena.\u00a0 OptimizeRx\u00a0was recognized as a finalist in the category of\u00a0COVID-19 Pandemic-Related Campaign.<\/p>\n<p align=\"left\">OptimizeRx\u00a0was selected as a finalist for its COVID-19 Consumer Health Communications Text Message Campaign. The campaign leveraged OptimizeRx\u2019s text-based patient engagement technology, which is traditionally used for specific therapy support programs, to provide the general public with timely COVID-19 information from a reliable source. The free, interactive <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=feaFqaNZRp9PokSi4egJF1RDblAbNl1b95iaX5gdFgl3-xPb0xWs9P_mUp9YYJ27fWiVSdcDfVnpVZKnlN74Ep_ZVDiz9fUz2kRqtLLN1Rxy8WrWuhkfiRF5EWJxGc5_wfJ5fjqr9iOPzEHGSMgPOXaeAADOynCQfDEomCX-6oXcgiBVIpUVRw3KNSDnC5g5dVnB1DrNhTKRpPQznwBtyAUA7Dp6tcb7m30T7qzP3Ic=\" rel=\"nofollow noopener\" target=\"_blank\">text-message alert program<\/a> delivered COVID-19 updates sourced from the Center for Disease Control and Prevention (CDC) directly to any SMS-enabled mobile device.<\/p>\n<p align=\"left\">Fierce Pharma Marketing\u2019s expert panel of judges reviewed all submissions to determine which companies produced thought-provoking, innovative and compelling campaigns across a wide range of media. A full list of judges can be found at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hUAZ0zaum-KeMohXsBEUVlA7dfKXgMymrvaCz5gXa7Cl7si9hiD8B43ttApvWTiJqXmjtHB5KvVnzasnyjckdvmh2sg8ybDmT0nF7QKuDYUQ3B3TJn656JE3Ozj_6O2SPL4iE3aajHYT2iF_uHKMUhtyySJG82CbHV_nT_v9wyY=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.fiercemarketingforum.com\/2021%20judges<\/a>. <\/p>\n<p align=\"left\">The winners will be announced at the Fierce Pharma Marketing Awards Dinner on September 29 at the Pennsylvania Convention Center in Philadelphia, as part of the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0ldDa6Hcuu1scaIPkh_qqgEgfh5FyGPPNkq5dtwqaoRd4yOQwN_gamzetXZxAjMZEnv_CUUkMVqUd3tLdIeGvINTpRDe47bmLhIi2dDWdcG2hUjJcSHNEg7liCwN0mtH\" rel=\"nofollow noopener\" target=\"_blank\">Digital Pharma East Conference<\/a>. The event is sponsored by DeepIntent, DrFirst and Doximity.<\/p>\n<p align=\"left\">\u201cIt\u2019s been a challenging year for pharma, but it\u2019s also been a creative and innovative one. Pharma marketers and their agencies quickly embraced pandemic-forced changes\u2014moving to digital communications and figuring out how to shoot TV commercials safely, for instance\u2014and continued to produce creative and compelling campaigns all year. We look forward to seeing everybody in Philadelphia in September where we will reveal the winning entries,\u201d commented Tracy Station, Editor-in-Chief, Fierce Pharma. \u201cWe applaud OptimizeRx on their success.\u201d<\/p>\n<p align=\"left\">William Febbo, OptimizeRx\u2019s CEO commented, \u201cWe are honored to be in such good company in this category and be recognized for our \u201cCOVID-19 Consumer Health\u201d campaign. Leveraging OptimizeRx\u2019s best-in-class integrated technology platform for life sciences communications to serve the general public during the height of the pandemic was a testament to the invaluable power of technology in healthcare.<\/p>\n<p align=\"left\">\u201cSMS campaigns are just one of our access solutions that doctors, and life sciences organizations can utilize to facilitate patient engagement outside of the electronic health record in a familiar and convenient manner. It was a no-brainer for our team to leverage the capabilities of the OptimizeRx platform to provide free access to timely and reliable COVID-19 updates, sourced from the CDC. This helped increase accessibility to CDC guidelines on-demand and via automatic notifications so the general public could stay more informed\u201d concluded Mr. Febbo.<\/p>\n<p align=\"left\">OptimizeRx will be <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eosvyqnAqtv8Rr4J3RRkPDNuouZ1pt3AZ8dTq21Kf-jqZOcUQWcN7ZHd7GPVBsE_atAJ24PVanzG-pLATjoNTvUgN_DTkFsUhV7AoWcPOhoim3PsI37Av6C3826pL_WE\" rel=\"nofollow noopener\" target=\"_blank\">present<\/a> at this year\u2019s Digital Pharma East Conference in Philadelphia at booth number MK1, September 28-30, and at the virtual event, October 5-8.<\/p>\n<p align=\"left\">\n        <strong>About Questex<\/strong><br \/>\n        <br \/>\n        <strong>Questex helps people live better and longer<\/strong>. Questex\u00a0brings people together in the markets that help people\u00a0<strong>live better<\/strong>:\u00a0travel, hospitality\u00a0and\u00a0wellness; the industries that help people\u00a0<strong>live longer<\/strong>:\u00a0life science\u00a0and\u00a0healthcare;\u00a0and the\u00a0technologies\u00a0that enable and fuel these\u00a0<strong>new experiences<\/strong>. We live in <strong>the\u00a0experience economy <\/strong>\u2013\u00a0connecting\u00a0our\u00a0ecosystem through\u00a0live events, surrounded by data insights and digital communities. We deliver experience and real results.\u00a0<strong>It happens here.<\/strong><\/p>\n<p align=\"left\">\n        <strong>About OptimizeRx<\/strong><br \/>\n        <br \/>OptimizeRx is a digital health company that provides communications solutions for life science companies, physicians and patients. Connecting over half of healthcare providers in the U.S. and millions of patients through a proprietary network, the OptimizeRx digital health platform helps patients afford and stay on medications. The platform unlocks new patient and physician touchpoints for life science companies along the patient journey, from point-of-care, to retail pharmacy, through mobile patient engagement.<\/p>\n<p align=\"left\">For more information, follow the company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=67CEZN7ogGeCC_Fr2kN-jqwDuwwaGlnAU3U_9UIoUaFbkx7PLoP_75Kr1EuRV-AGcbygiawt23h1jZHnS82E9w==\" rel=\"nofollow noopener\" target=\"_blank\"><u>Twitter<\/u><\/a>,\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zls0mOSCOUDGOAXqACwLNpiuErkE7Uhgqj2FgzeNNC7Ol1xjiY0bwjBU3YVXoWkj7o0Uht0HWtJwDxJCwyh7DCYHAjp-vHeRHaY6Gpy70Yk=\" rel=\"nofollow noopener\" target=\"_blank\"><u>LinkedIn<\/u><\/a>\u00a0or visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3Cq58S2CHSOKsgrT6iSWBPNysOzNk7eeKRsx68eWKaaVgPQHJ7nIQYRU6Qj8_3Og5-bKo1ikElDoMQl1WVqVoBPIizy9tjbVAlSqu8BmZkI=\" rel=\"nofollow noopener\" target=\"_blank\"><u>www.optimizerx.com<\/u><\/a>.\u00a0<\/p>\n<p align=\"left\">\n        <strong>Important Cautions Regarding Forward Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words &#8216;estimate,&#8217; &#8216;possible&#8217; and &#8216;seeking&#8217; and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.<\/p>\n<p align=\"left\">\n        <strong>OptimizeRx\u00a0Contact<\/strong>\u00a0<br \/>Doug Baker, CFO<br \/>Tel (248) 651-6568 (x807)<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IL4U3mcCsYsWJ7MQ4vpJNXoMZCYfAQxEucaj6rSSrIjG92fEPQDCUpomKAj2kLpqZ9dtFPLGrnB1iS9GzCHg9Pb9ROuX1HX44pzXEueCL7I=\" rel=\"nofollow noopener\" target=\"_blank\"><u>dbaker@optimizerx.com<\/u><\/a>\u00a0<\/p>\n<p align=\"left\">\n        <strong>Media Relations Contact<\/strong>\u00a0<br \/>Maira Alejandra, Media Relations Manager<br \/>Tel (754) 245-7070\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jRdUdCZp9xD1ZfO3oC6qHxLhboOGVL48-Z_Vq19ofvNWf1jejCAyO7mSoIpfg33EHLsIx1jkzBQxWDEC5KsaZ__V2yUDECqcfPZyaI-asw1YGNsZ-DS3J_GIbIJ-yj7-\" rel=\"nofollow noopener\" target=\"_blank\"><u>malejandra@optimizerx.com<\/u><\/a><u>\u00a0<\/u><\/p>\n<p align=\"left\">\n        <strong>Investor Relations Contact<\/strong><br \/>\n        <br \/>Ashley Robinson<br \/>LifeSci Advisors, LLC<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7PoBjpcaQ43dBLd6pEN9mucPoBUwppuv7DcVumGvatUHfS5LdXnh9idX9kVNGADrGL4yTBjLisDqi_HE2IgeTYev_2flp1u0cBoukvXZ8U8=\" rel=\"nofollow noopener\" target=\"_blank\">arr@lifesciadvisors.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Jennifer Woods <\/strong><br \/>\n        <br \/>Vice President, Fierce Life Sciences Events<br \/>Questex <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=hCt-MX-sIlrN8J-txVypYguQ_O0zzkW1ZJoGS5DNrovWjDfQUWdtZSivIRQCeTlGloKPOOjyLwqZ9BH3uEnVQEeQOyCu1vjeDPgO-VFwJ4E=\" rel=\"nofollow noopener\" target=\"_blank\">jwoods@questex.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MzBmMjMyZTQtZDcxNy00NjcwLWE5NTUtMDc1YmFkMGQzZTZiLTEwNjE0NTU=\/tiny\/OptimizeRx-Corporation.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>OptimizeRx Recognized in the COVID-19 Pandemic-Related Campaign Category ROCHESTER, Mich., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; OptimizeRx Corp. (the \u201cCompany\u201d) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that it has been selected as a finalist in the 2021 Fierce Pharma Marketing Awards which honor leadership, vision, innovation and strategic accomplishments within the pharma marketing and advertising arena.\u00a0 OptimizeRx\u00a0was recognized as a finalist in the category of\u00a0COVID-19 Pandemic-Related Campaign. OptimizeRx\u00a0was selected as a finalist for its COVID-19 Consumer Health Communications Text Message Campaign. The campaign leveraged OptimizeRx\u2019s text-based patient engagement technology, which is traditionally used for specific therapy support programs, to provide the general public with timely COVID-19 information from &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534772","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"OptimizeRx Recognized in the COVID-19 Pandemic-Related Campaign Category ROCHESTER, Mich., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; OptimizeRx Corp. (the \u201cCompany\u201d) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that it has been selected as a finalist in the 2021 Fierce Pharma Marketing Awards which honor leadership, vision, innovation and strategic accomplishments within the pharma marketing and advertising arena.\u00a0 OptimizeRx\u00a0was recognized as a finalist in the category of\u00a0COVID-19 Pandemic-Related Campaign. OptimizeRx\u00a0was selected as a finalist for its COVID-19 Consumer Health Communications Text Message Campaign. The campaign leveraged OptimizeRx\u2019s text-based patient engagement technology, which is traditionally used for specific therapy support programs, to provide the general public with timely COVID-19 information from &hellip; Continue reading &quot;OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-07T12:04:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021\",\"datePublished\":\"2021-09-07T12:04:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/\"},\"wordCount\":855,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/\",\"name\":\"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=\",\"datePublished\":\"2021-09-07T12:04:54+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/","og_locale":"en_US","og_type":"article","og_title":"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021 - Market Newsdesk","og_description":"OptimizeRx Recognized in the COVID-19 Pandemic-Related Campaign Category ROCHESTER, Mich., Sept. 07, 2021 (GLOBE NEWSWIRE) &#8212; OptimizeRx Corp. (the \u201cCompany\u201d) (Nasdaq: OPRX), a leading provider of digital health solutions for life science companies, physicians and patients, announced today that it has been selected as a finalist in the 2021 Fierce Pharma Marketing Awards which honor leadership, vision, innovation and strategic accomplishments within the pharma marketing and advertising arena.\u00a0 OptimizeRx\u00a0was recognized as a finalist in the category of\u00a0COVID-19 Pandemic-Related Campaign. OptimizeRx\u00a0was selected as a finalist for its COVID-19 Consumer Health Communications Text Message Campaign. The campaign leveraged OptimizeRx\u2019s text-based patient engagement technology, which is traditionally used for specific therapy support programs, to provide the general public with timely COVID-19 information from &hellip; Continue reading \"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-07T12:04:54+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021","datePublished":"2021-09-07T12:04:54+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/"},"wordCount":855,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/","name":"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=","datePublished":"2021-09-07T12:04:54+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMyMDE1NiM0Mzg4ODYwIzIwNDk4ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/optimizerx-recognized-as-a-finalist-in-questexs-fierce-pharma-marketing-awards-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"OptimizeRx Recognized as a Finalist in Questex\u2019s Fierce Pharma Marketing Awards 2021"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534772","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534772"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534772\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534772"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534772"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534772"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}